This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Memorial Sloan Kettering Cancer Center, The United States of America, as Represented by the Secretary, Department of Health and Human Services, Tri-Institutional Therapeutics Discovery Institute. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 621 
1 out of 3,699 
1 out of 11 Years Active: 2025
Title: Nayanendu Saha: Innovator in Cancer Treatment
Introduction
Nayanendu Saha is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of binding molecules.
Latest Patents
Nayanendu Saha holds a patent for "ADAM17 binding molecules and uses thereof." This invention provides various ADAM17 binding molecules, including antibodies and fragments, along with compositions that utilize these molecules. The methods described in the patent focus on inhibiting the binding of ADAM17 to its substrates, such as ErbB ligands, which can lead to the inhibition of cancer cell proliferation and offer potential treatments for cancer.
Career Highlights
Throughout his career, Nayanendu Saha has demonstrated a commitment to advancing medical science, particularly in oncology. His work has been recognized for its potential impact on cancer therapies, showcasing his dedication to improving patient outcomes.
Collaborations
Nayanendu has collaborated with notable researchers, including Dimitar Nikolov and Zhongyu Zhu, to further enhance the development of his inventions and contribute to the scientific community.
Conclusion
Nayanendu Saha's innovative work in developing ADAM17 binding molecules represents a significant advancement in cancer treatment. His contributions highlight the importance of research and collaboration in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile